Search research articles
Contact Us
Filters
Showing results (1-10 of 17) with videos related to
Page
of 2
Sort By:
Journal of Exposure Science & Environmental Epidemiology
|
November 17, 2006
Reverse dosimetry: interpreting trihalomethanes biomonitoring data using physiologically based pharmacokinetic modeling
Yu-Mei Tan, Kai H Liao, Harvey J Clewell
Risk Analysis : an Official Publication of the Society for Risk Analysis
|
December 14, 2007
Development of a screening approach to interpret human biomonitoring data on volatile organic compounds: reverse dosimetry on biomonitoring data for trichloroethylene
Kai H Liao, Yu-Mei Tan, Harvey J Clewell
The AAPS Journal
|
March 7, 2024
Implications of Immunogenicity Testing for Therapeutic Monoclonal Antibodies: A Quantitative Pharmacology Framework
Jason H Williams, Kai H Liao, Donghua Yin, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
October 21, 2005
Dose-incidence modeling: consequences of linking quantal measures of response to depletion of critical tissue targets
Melvin E Andersen, Roman W Lutz, Kai H Liao, et al.
The AAPS Journal
|
June 10, 2022
Joint Disposition Properties and Comprehensive Pharmacokinetic Characterization of Antibody-Drug Conjugates
Kai H Liao, Jason H Williams, Santhosh Palani, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
August 3, 2005
A novel, sensitive method for determining benzo[a]pyrene-diones using high-performance liquid chromatography with post-column zinc reduction
Kai H Liao, Arthur N Mayeno, Kenneth F Reardon, et al.
Journal of Toxicology and Environmental Health. Part A
|
April 15, 2010
Bayesian analysis of a rat formaldehyde DNA-protein cross-link model
Yuching Yang, Bruce C Allen, Yu-Mei Tan, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
November 17, 2022
PK/PD model-informed dose selection for oncology phase I expansion: Case study based on PF-06939999, a PRMT5 inhibitor
Cen Guo, Kai H Liao, Meng Li, et al.
British Journal of Clinical Pharmacology
|
April 15, 2020
A mechanistic pharmacokinetic model with drug and antidrug antibody interplay, and its application for assessing the impact of immunogenicity response on bioequivalence testing
Kai H Liao, Chandrasekhar Udata, Donghua Yin, et al.
Inhalation Toxicology
|
February 28, 2008
Assessing kinetic determinants for metabolism and oral uptake of octamethylcyclotetrasiloxane (D4) from inhalation chamber studies
Ivan D Dobrev, Andy Nong, Kai H Liao, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 17) with videos related to
Sort By:
Page
of 2
Journal of Exposure Science & Environmental Epidemiology
|
November 17, 2006
Reverse dosimetry: interpreting trihalomethanes biomonitoring data using physiologically based pharmacokinetic modeling
Yu-Mei Tan, Kai H Liao, Harvey J Clewell
Risk Analysis : an Official Publication of the Society for Risk Analysis
|
December 14, 2007
Development of a screening approach to interpret human biomonitoring data on volatile organic compounds: reverse dosimetry on biomonitoring data for trichloroethylene
Kai H Liao, Yu-Mei Tan, Harvey J Clewell
The AAPS Journal
|
March 7, 2024
Implications of Immunogenicity Testing for Therapeutic Monoclonal Antibodies: A Quantitative Pharmacology Framework
Jason H Williams, Kai H Liao, Donghua Yin, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
October 21, 2005
Dose-incidence modeling: consequences of linking quantal measures of response to depletion of critical tissue targets
Melvin E Andersen, Roman W Lutz, Kai H Liao, et al.
The AAPS Journal
|
June 10, 2022
Joint Disposition Properties and Comprehensive Pharmacokinetic Characterization of Antibody-Drug Conjugates
Kai H Liao, Jason H Williams, Santhosh Palani, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
August 3, 2005
A novel, sensitive method for determining benzo[a]pyrene-diones using high-performance liquid chromatography with post-column zinc reduction
Kai H Liao, Arthur N Mayeno, Kenneth F Reardon, et al.
Journal of Toxicology and Environmental Health. Part A
|
April 15, 2010
Bayesian analysis of a rat formaldehyde DNA-protein cross-link model
Yuching Yang, Bruce C Allen, Yu-Mei Tan, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
November 17, 2022
PK/PD model-informed dose selection for oncology phase I expansion: Case study based on PF-06939999, a PRMT5 inhibitor
Cen Guo, Kai H Liao, Meng Li, et al.
British Journal of Clinical Pharmacology
|
April 15, 2020
A mechanistic pharmacokinetic model with drug and antidrug antibody interplay, and its application for assessing the impact of immunogenicity response on bioequivalence testing
Kai H Liao, Chandrasekhar Udata, Donghua Yin, et al.
Inhalation Toxicology
|
February 28, 2008
Assessing kinetic determinants for metabolism and oral uptake of octamethylcyclotetrasiloxane (D4) from inhalation chamber studies
Ivan D Dobrev, Andy Nong, Kai H Liao, et al.
Page
of 2